Skip to content

Promoting Recovery Optimization With WALKing Exercise After Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02835313
Acronym
PROWALKS
Enrollment
250
Registered
2016-07-18
Start date
2016-07-18
Completion date
2023-12-31
Last updated
2024-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

Stroke survivors, as a group, are extremely inactive and this has serious consequences for them, including an increased risk of a second stroke and developing other diseases. This study investigates a novel intervention designed to improve everyday activity after stroke by combining walking training to improve walking capacity with a program to encourage more daily walking.

Detailed description

As a group, stroke survivors are more physically inactive than even the most sedentary older adults. Lack of physical activity has serious consequences in persons with stroke, including an increased risk of recurrent stroke, developing other diseases and mortality. Current rehabilitation interventions do little to improve real-world walking activity after stroke, suggesting that simply improving walking capacity is not sufficient for improving daily physical activity after stroke. Rather, the investigator's hypothesize that the combination of a fast walking intervention that improves walking capacity, with a step activity monitoring program that facilitates translation of gains from the clinic to the real-world, would generate greater improvements in real world walking activity than with either intervention alone. Data from the investigator's lab provides support for this hypothesis; however, it suggests that the greater efficacy of combining the 2 interventions depends on a participant's initial walking activity. Thus, the investigator's do not expect that one intervention will be superior to the others for all participants, but rather that the combined intervention will be superior for those with low levels of baseline walking activity, speed and endurance. The specific objective of this study is to test whether and for whom combining fast walking training with a step activity monitoring program (FAST+SAM) is superior in improving real-world walking activity compared to fast walking training alone (FAST) or a step activity monitoring and feedback program alone (SAM) in those with chronic stroke. Using a randomized controlled experimental design, 225 chronic (\> 6 months) stroke survivors, will complete 12 weeks of fast walking training (FAST), a step activity monitoring program (SAM) or a fast walking training + step activity monitoring program (FAST+SAM). Moderation of specific intervention outcomes by baseline characteristics will be evaluated to determine for whom the interventions are effective.

Interventions

BEHAVIORALFAST alone

Subjects participate in fast walking training 3x/week for 12 weeks.

BEHAVIORALFAST+SAM

Subjects participate in fast walking training plus a step activity monitoring program 3x/week for 12 weeks

BEHAVIORALSAM alone

Subjects participate in a step activity monitoring program 3x/week for 12 weeks

Sponsors

University of Pennsylvania
CollaboratorOTHER
Christiana Care Health Services
CollaboratorOTHER
Indiana University
CollaboratorOTHER
University of Delaware
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Age 21-85 2. Chronic stroke (\>6 months post stroke) 3. Able to walk at self-selected speed without assistance from another person (assistive devices are allowed) 4. Self-selected walking speed \>0.3 m/s and \<1.0 m/s 5. Average steps/day \<8,000 6. Resting heart rate between 40-100 beats per minute 7. Resting blood pressure between 90/60 to 170/90.

Exclusion criteria

1. Evidence of cerebellar stroke 2. Other potentially disabling neurologic conditions in addition to stroke 3. Lower limb Botulinum toxin injection \<4 months earlier 4. Current participation in physical therapy 5. Inability to walk outside the home prior to the stroke 6. Coronary artery bypass graft, stent placement or myocardial infarction within past 3 months 7. Musculoskeletal pain that limits activity 8. Inability to communicate with investigators 9. score \>1 on question 1b and \>0 on question 1c on the NIH Stroke Scale.

Design outcomes

Primary

MeasureTime frameDescription
Steps Per DayChange from Baseline to 3 months (Post)average change in steps per day between two time points, measured over at least a 3-day period for each time point

Secondary

MeasureTime frameDescription
Six-minute Walk Test DistanceChange from Baseline to 3 months (Post)change between two time points in endurance (measured by distance attained on the 6 minute walk test)
Self-selected Gait SpeedChange from Baseline to 3 months (Post)change between two time points in average self-selected speed on the 10m walk test
Oxygen ConsumptionChange from Baseline to 3 months (Post)change between two time points in average oxygen consumption at ventilatory threshold

Countries

United States

Participant flow

Participants by arm

ArmCount
FAST+SAM
Subjects participate in fast walking training in combination with a step activity monitoring program FAST+SAM: Subjects participate in fast walking training plus a step activity monitoring program 3x/week for 12 weeks
80
FAST Alone
Subjects participate in fast walking training FAST: Subjects participate in fast walking training 3x/week for 12 weeks.
89
SAM Alone
Subjects participate in a step activity monitoring program SAM: Subjects participate in a step activity monitoring program 3x/week for 12 weeks
81
Total250

Baseline characteristics

CharacteristicFAST AloneSAM AloneFAST+SAMTotal
Age, Continuous63 years
STANDARD_DEVIATION 11.96
62 years
STANDARD_DEVIATION 12.91
62 years
STANDARD_DEVIATION 13.07
63 years
STANDARD_DEVIATION 12.61
Ambulatory assistive device use46 Participants47 Participants36 Participants129 Participants
Body mass index29.79 kg/m^2
STANDARD_DEVIATION 6.39
31.58 kg/m^2
STANDARD_DEVIATION 7.05
30.13 kg/m^2
STANDARD_DEVIATION 5.45
30.48 kg/m^2
STANDARD_DEVIATION 6.35
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants2 Participants3 Participants10 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
84 Participants79 Participants77 Participants240 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Lower extremity orthotic use21 Participants25 Participants22 Participants68 Participants
Race/Ethnicity, Customized
American Indian or Alaskan Native
1 Participants0 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Asian
7 Participants2 Participants4 Participants13 Participants
Race/Ethnicity, Customized
Black or African American
20 Participants26 Participants20 Participants66 Participants
Race/Ethnicity, Customized
More than one race
5 Participants5 Participants6 Participants16 Participants
Race/Ethnicity, Customized
Native Hawaiian or Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Unknown or not reported
1 Participants0 Participants1 Participants2 Participants
Race/Ethnicity, Customized
White
55 Participants48 Participants49 Participants152 Participants
Region of Enrollment
United States
89 participants81 participants80 participants250 participants
Self-selected gait speed0.71 meters/sec
STANDARD_DEVIATION 0.2
0.68 meters/sec
STANDARD_DEVIATION 0.22
0.68 meters/sec
STANDARD_DEVIATION 0.22
0.69 meters/sec
STANDARD_DEVIATION 0.21
Sex: Female, Male
Female
41 Participants39 Participants36 Participants116 Participants
Sex: Female, Male
Male
48 Participants42 Participants44 Participants134 Participants
Side of hemiparesis
Both affected
3 Participants5 Participants4 Participants12 Participants
Side of hemiparesis
Left
43 Participants42 Participants39 Participants124 Participants
Side of hemiparesis
Right
43 Participants34 Participants37 Participants114 Participants
Six-minute walk test distance296 meters
STANDARD_DEVIATION 113
279 meters
STANDARD_DEVIATION 110
283 meters
STANDARD_DEVIATION 122
287 meters
STANDARD_DEVIATION 115
Steps per day3959 steps/day
STANDARD_DEVIATION 2021
3845 steps/day
STANDARD_DEVIATION 2193
3768 steps/day
STANDARD_DEVIATION 2074
3861 steps/day
STANDARD_DEVIATION 2088
Time since stroke46 months
STANDARD_DEVIATION 62.25
46 months
STANDARD_DEVIATION 73.22
42 months
STANDARD_DEVIATION 48.75
45 months
STANDARD_DEVIATION 62.04
VO2 at ventilatory threshold8.77 mL/kg per min
STANDARD_DEVIATION 2.98
9.37 mL/kg per min
STANDARD_DEVIATION 2.66
9.63 mL/kg per min
STANDARD_DEVIATION 3.35
9.24 mL/kg per min
STANDARD_DEVIATION 3.02

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 801 / 890 / 81
other
Total, other adverse events
25 / 8038 / 8919 / 81
serious
Total, serious adverse events
14 / 809 / 893 / 81

Outcome results

Primary

Steps Per Day

average change in steps per day between two time points, measured over at least a 3-day period for each time point

Time frame: Change from Baseline to 3 months (Post)

ArmMeasureValue (MEAN)
FAST+SAMSteps Per Day1307 steps per day
FAST AloneSteps Per Day406 steps per day
SAM AloneSteps Per Day1542 steps per day
Primary

Steps Per Day

average change in steps per day between two time points, measured over at least a 3-day period for each time point

Time frame: Change from 3 months (Post) to 6 months

ArmMeasureValue (MEAN)
FAST+SAMSteps Per Day-400 steps per day
FAST AloneSteps Per Day-160 steps per day
SAM AloneSteps Per Day-1016 steps per day
Primary

Steps Per Day

average change in steps per day between two time points, measured over at least a 3-day period for each time point

Time frame: Change from 3 months (Post) to 12 months

ArmMeasureValue (MEAN)
FAST+SAMSteps Per Day-568 steps per day
FAST AloneSteps Per Day-610 steps per day
SAM AloneSteps Per Day-1072 steps per day
Secondary

Oxygen Consumption

change between two time points in average oxygen consumption at ventilatory threshold

Time frame: Change from 3 months (Post) to 12 months

ArmMeasureValue (MEAN)
FAST+SAMOxygen Consumption-0.08 mL/kg/min
FAST AloneOxygen Consumption-1.32 mL/kg/min
SAM AloneOxygen Consumption-0.15 mL/kg/min
Secondary

Oxygen Consumption

change between two time points in average oxygen consumption at ventilatory threshold

Time frame: Change from Baseline to 3 months (Post)

ArmMeasureValue (MEAN)
FAST+SAMOxygen Consumption0.31 mL/kg/min
FAST AloneOxygen Consumption0.27 mL/kg/min
SAM AloneOxygen Consumption0.01 mL/kg/min
Secondary

Oxygen Consumption

change between two time points in average oxygen consumption at ventilatory threshold

Time frame: Change from 3 months (Post) to 6 months

ArmMeasureValue (MEAN)
FAST+SAMOxygen Consumption-0.32 mL/kg/min
FAST AloneOxygen Consumption-0.53 mL/kg/min
SAM AloneOxygen Consumption0.13 mL/kg/min
Secondary

Self-selected Gait Speed

change between two time points in average self-selected speed on the 10m walk test

Time frame: Change from Baseline to 3 months (Post)

ArmMeasureValue (MEAN)
FAST+SAMSelf-selected Gait Speed0.14 meters/sec
FAST AloneSelf-selected Gait Speed0.13 meters/sec
SAM AloneSelf-selected Gait Speed0.11 meters/sec
Secondary

Self-selected Gait Speed

change between two time points in average self-selected speed on the 10m walk test

Time frame: Change from 3 months (Post) to 6 months

ArmMeasureValue (MEAN)
FAST+SAMSelf-selected Gait Speed-0.02 meters/sec
FAST AloneSelf-selected Gait Speed-0.03 meters/sec
SAM AloneSelf-selected Gait Speed-0.02 meters/sec
Secondary

Self-selected Gait Speed

change between two time points in average self-selected speed on the 10m walk test

Time frame: Change from 3 months (Post) to 12 months

ArmMeasureValue (MEAN)
FAST+SAMSelf-selected Gait Speed-0.02 meters/sec
FAST AloneSelf-selected Gait Speed-0.05 meters/sec
SAM AloneSelf-selected Gait Speed-0.04 meters/sec
Secondary

Six-minute Walk Test Distance

change between two time points in endurance (measured by distance attained on the 6 minute walk test)

Time frame: Change from Baseline to 3 months (Post)

ArmMeasureValue (MEAN)
FAST+SAMSix-minute Walk Test Distance39 meters
FAST AloneSix-minute Walk Test Distance43 meters
SAM AloneSix-minute Walk Test Distance25 meters
Secondary

Six-minute Walk Test Distance

change between two time points in endurance (measured by distance attained on the 6 minute walk test)

Time frame: Change from 3 months (Post) to 6 months

ArmMeasureValue (MEAN)
FAST+SAMSix-minute Walk Test Distance-13 meters
FAST AloneSix-minute Walk Test Distance-10 meters
SAM AloneSix-minute Walk Test Distance-15 meters
Secondary

Six-minute Walk Test Distance

change between two time points in endurance (measured by distance attained on the 6 minute walk test)

Time frame: Change from 3 months (Post) to 12 months

ArmMeasureValue (MEAN)
FAST+SAMSix-minute Walk Test Distance-18 meters
FAST AloneSix-minute Walk Test Distance-21 meters
SAM AloneSix-minute Walk Test Distance-16 meters

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026